Forskolin enhances in vivo bone formation by human mesenchymal stromal cells

Tissue Engineering - Part A

Volumn 18, Issue 5-6, 2012, Pages 558-567

  Doorn, Joyce ^a   Siddappa, Ramakrishnaiah ^a   Van Blitterswijk, Clemens A ^a   De Boer, Jan ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; GENES; PHOSPHATASES;

8-BR-CAMP; ADIPOGENIC; ALKALINE PHOSPHATASE; BONE FORMATION; DIBUTYRYL CYCLIC ADENOSINE MONOPHOSPHATE; DOSE-DEPENDENT MANNER; FORSKOLIN; IN-VITRO; IN-VIVO; INHIBITORY EFFECT; INSULIN-LIKE GROWTH FACTOR-1; LONG-TERM CULTURE; MESENCHYMAL STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; PROTEIN KINASE A; TARGET GENES;

BONE;

8 BROMO CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIFFERENTIATION ANTIGEN; FORSKOLIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; TRANSPLANTATION; XENOGRAFT;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FORSKOLIN; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; OSTEOGENESIS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84857862385     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0312     Document Type: Article

References (52)

1. Pittenger, M.F., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
2. Brazelton, T.R., et al. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290, 1775, 2000.
3. Mezey, E., et al. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290, 1779, 2000.
4. Oswald, J., et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem cells 22, 377, 2004.
5. Dezawa, M., et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309, 314, 2005.
6. Shake, J.G., et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73, 1919, 2002.
7. Bruder, S.P., et al. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80, 985, 1998.
8. Kon, E., et al. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 49, 328, 2000.
9. Petite, H., et al. Tissue-engineered bone regeneration. Nat Biotechnol 18, 959, 2000.
10. Boyde, A., et al. Osteoconduction in large macroporous hydroxyapatite ceramic implants: evidence for a complementary integration and disintegration mechanism. Bone 24, 579, 1999.
11. Jeon, O., et al. In vivo bone formation following transplantation of human adipose-derived stromal cells that are not differentiated osteogenically. Tissue Eng Part A 14, 1285, 2008.
12. Meijer, G.J., et al. Cell-based bone tissue engineering. PLoS Med 4, e9, 2007.
13. Oliveira, J.M., et al. Ex vivo culturing of stromal cells with dexamethasone-loaded carboxymethylchitosan/poly(-amidoamine) dendrimer nanoparticles promotes ectopic bone formation. Bone 46, 1424, 2010.
14. Kang, S.-W., et al. Enhancement of in vivo bone regeneration efficacy of human mesenchymal stem cells. J Microbiol Biotechnol 18, 975, 2008.
15. Song, I.-H., Caplan, A.I., and Dennis, J.E. In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo. J Orthop Res 27, 916, 2009.
16. De Kok, I.J., et al. Effect of vitamin D pretreatment of human mesenchymal stem cells on ectopic bone formation. J Oral Implantol 32, 103, 2006.
17. De Boer, J., et al. Inhibition of histone acetylation as a tool in bone tissue engineering. Tissue Eng 12, 2927, 2006.
18. De Boer, J., Wang, H.J., and Van Blitterswijk, C.A. Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng 10, 393, 2004.
19. Mendes, S.C., et al. Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells. J Mater Sci Mater Med 15, 1123, 2004.
20. Siddappa, R., et al. cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci USA 105, 7281, 2008.
21. Roth, J.A., et al. Melatonin promotes osteoblast differentiation and bone formation. J Biol Chem 274, 22041, 1999.
22. Kaneki, H., et al. Prostaglandin E2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts. J Cell Biochem 73, 36, 1999.
23. Swarthout, J.T., et al. Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 282, 1, 2002.
24. Selvamurugan, N., et al. Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alpha 1. J Biol Chem 275, 5037, 2000.
25. Boguslawski, G., et al. Activation of osteocalcin transcription involves interaction of protein kinase A-and protein kinase C-dependent pathways. J Biol Chem 275, 999, 2000.
26. de Bruijn, J.D., et al. Bone induction by implants coated with cultured osteogenic bone marrow cells. Adv Dent Res 13, 74, 1999.
27. Livak, K.J., and Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25, 402, 2001.
28. Yuan, H., et al. A comparison of the osteoinductive potential of two calcium phosphate ceramics implanted intramuscularly in goats. J Mater Sci Mater Med 13, 1271, 2002.
29. Hong, S.H.H., et al. Regulation of osterix (Osx, Sp7) and the Osx promoter by parathyroid hormone in osteoblasts. J Mol Endocrinol 43, 197, 2009.
30. Siddappa, R., et al. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 25, 1029, 2007.
31. Eyckmans, J., et al. A clinically relevant model of osteoinduction: a process requiring calcium phosphate and BMP/Wnt signalling. J Cell Mol Med 14, 1845, 2009.
32. Stenderup, K., et al. Aged human bone marrow stromal cells maintaining bone forming capacity in vivo evaluated using an improved method of visualization. Biogerontology 5, 107, 2004.
33. Mills, I., Moreno, F.J., and Fain, J.N. Forskolin inhibition of glucose metabolism in rat adipocytes independent of adenosine 3',5'-monophosphate accumulation and lipolysis. Endocrinology 115, 1066, 1984.
34. Tirapelli, C.R., et al. Hypotensive action of naturally occurring diterpenes: A therapeutic promise for the treatment of hypertension. Fitoterapia 81, 690, 2010.
35. Huang, R.D., Smith, M.F., and Zahler, W.L., Inhibition of forskolin-activated adenylate cyclase by ethanol and other solvents. J Cyclic Nucleotide Res 8, 385, 1982.
36. Kramer, W., Thormann, J., Kindler, M., and Schlepper, M., Effects of forskolin on left ventricular function in dilated cardiomyopathy. Arzneimittelforschung 3, 364, 1987.
37. Schlepper, M., Thormann, J., and Mitrovic, V., Cardiovascular effects of forskolin and phosphodiesterase-III inhibitors. Basic Res Cardiol 84, 197, 1989.
38. Siddappa, R., et al. Timing, rather than the concentration of cyclic AMP, correlates to osteogenic differentiation of human mesenchymal stem cells. J Tissue Eng Regen Med 4, 356, 2010.
39. Petersen, R.K., et al. Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of epac-and cAMP-dependent protein kinasedependent processes. Mol Cell Biol 28, 3804, 2008.
40. Bos, J.L., Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci 31, 680, 2006.
41. Gupta, S., Samanta, M.K., and Raichur, A.M. Dual-drug delivery system based on in situ gel-forming nanosuspension of forskolin to enhance antiglaucoma efficacy. AAPS Pharm Sci Tech 11, 322, 2010.
42. Caprioli, J., and Sears, M. Forskolin lowers intraocular pressure in rabbits, monkeys, and man. The Lancet 321, 958, 1983.
43. Wysham, D., Brotherton, A., and Heistad, D. Effects of forskolin on cerebral blood flow: implications for a role of adenylate cyclase. Stroke 17, 1299, 1986.
44. Yang, D.-c., et al. cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. PLoS ONE 3, e1540, 2008.
45. Zhao, Y., and Ding, S. A high-throughput siRNA library screen identifies osteogenic suppressors in human mesenchymal stem cells. Proc Natl Acad Sci USA 104, 9673, 2007.
46. Lo, K.W.H., et al. Activation of cyclic AMP/protein kinase: A signaling pathway enhances osteoblast cell adhesion on biomaterials for regenerative engineering. J Orthop Res 29, 602, 2011.
47. Pearse, D.D., et al. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med 10, 610, 2004.
48. Lee, J.-Y., et al. Cyclic AMP prolongs graft survival by suppressing apoptosis and inflammatory gene expression in acute cardiac allograft rejection. Exp Mol Med 42, 69, 2010.
49. Sweeney, T.M., Frankfurter, A., and Little, C.D. In vitro differentiation of neuron-like cells. Mol Cell Neurosci 1, 193, 1990.
50. Klapka, N., et al. Suppression of fibrous scarring in spinal cord injury of rat promotes long-distance regeneration of corticospinal tract axons, rescue of primary motoneurons in somatosensory cortex and significant functional recovery. Eur J Neurosci 22, 3047, 2005.
51. Rossato, J.I., et al. Dopamine controls persistence of longterm memory storage. Science 325, 1017, 2009.
52. Fujimoto, W., et al. Niflumic acid-sensitive ion channels play an important role in the induction of glucose-stimulated insulin secretion by cyclic AMP in mice. Diabetologia 52, 863, 2009.